We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

HYD Receives Approval for Phase 2 Clinical Trial

News   Jul 19, 2016

 
HYD Receives Approval for Phase 2 Clinical Trial
 
 
 

RELATED ARTICLES

Hindering Melanoma Metastasis with FDA-approved Drug

News

An FDA-approved drug has been identified that, when used with surgery, hampers metastasis in an animal model. Originally developed and approved ~65 years ago to control blood pressure, the medication resperine also prevents what are known as tumor-derived extracellular vesicles from fusing to healthy cells and sharing their cargo of disease-promoting molecules.

READ MORE

Costs and Complications of Lung Cancer Diagnostic Tests Underestimated

News

This study underscores the importance of sharing risks with patients considering lung cancer screening.

READ MORE

Comprehensive New Way to Predict Breast Cancer Risk

News

Scientists have created the most comprehensive method yet to predict a woman’s risk of breast cancer, according to a study by Cancer Research UK published in Genetics in Medicine.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE